Press release
Heart Pump Device Market is anticipated to reach up to USD 14.4 billion by 2032,
The global heart pump device market was valued at USD 2.5 billion in 2022, and it is anticipated to reach up to USD 14.4 billion by 2032, at a CAGR of 19.1% during the forecast period.New York, Global Heart Pump Device Market report from Global Insight Services is the single authoritative source of intelligence on Heart Pump Device Market . The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Get Free Sample Copy of This Report- https://www.globalinsightservices.com/request-sample/GIS10292
Millions of individuals around the world suffer from heart failure, which kills more people annually than all forms of cancer combined. Since there aren't enough donors for heart transplants, using a reliable mechanical circulatory support system could lengthen patients' lives and ease their pain. This device can be inserted into either the left or right ventricle of your heart, although the left ventricle is where it is most usually utilized. If a patient suffers heart failure and is not a suitable candidate for a heart transplant, the doctor may recommend having a VAD implanted as a long-term treatment. If you have severe heart failure, the procedure to install these devices-which necessitates open-heart surgery and carries significant risks and complications-can save your life. Following the implants, the patient must visit the doctor to discuss how the device is performing and, if necessary, any issues.
To know more about Heart Pump Device Market visit https://www.globalinsightservices.com/reports/heart-pump-device-market/-
Market Trends and Drivers
Due to the rising prevalence of CVDs and heart failure over the past several years, there has been a major increase in the demand for heart transplants. However, a global shortage issue has emerged due to the lack of sufficient hearts for transplantation to fulfill the current demand. There were roughly 3,980 candidates on the heart transplant waiting list as of March 2018, according to the national database maintained by the Health Resources and Services Administration (US).
Significant variations in the number of donors and patients on waiting lists have been seen, even at the national level. For instance, in Australia, there were around 1,650 people on the waiting list for a heart transplant in 2020, but there were only 463 donors available (Source: Transplant Australia Ltd). According to the Transplant Activity Report 2018/19, since 2010, there have been 134 percent more people active on waiting lists for heart transplants.
In this situation, there has been a rise in both the number of people waiting for transplants as well as the number of people passing away while on the list. Advanced heart failure (HF) management using LVADs as a bridge to transplantation (BTT) or destination therapy has become critical (DT). The need for mechanical circulatory support (MCS) devices used in these patients has increased as a result of organ shortages, the rise in end-stage HF patients, and technological advancements in MCS. 43 percent of recipients had some combination of MCS, LVAD, RVAD, TAH, and ECMO between 2009 and 2016. In the US, VADs were implanted in 50% of all adult heart transplant recipients between 2007 and 2017.
When a patient is not a candidate for a heart transplant, these devices also serve as a permanent solution, giving them the assistance, they need while they wait. In light of this, it is anticipated that the market for heart pump devices would expand over the next few years due to the substantial gap between the demand and availability of donor hearts.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10292
Global Heart Pump Device Market Segmentation
By Product
Ventricular Assist Devices
Intra-Aortic Balloon Pumps
Total Artificial Hearts
By Type
Implanted Heart Pump Device
Extracorporeal Heart Pump Device
By Therapy
Bridge-to-Transplant (BTT)
Bridge-to-Candidacy (BTC)
Destination Therapy (DT)
Other Therapies
By Region
North America
The U.S.
Canada
Mexico
Europe
The UK
Germany
France
Spain
Rest of Europe
The Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Rest of the World
Latin America
The Middle East
Africa
Purchase This Market Research Report -https://www.globalinsightservices.com/checkout/single_user/GIS10292/
Major Players in the Global Heart Pump Device Market
The key players studied in the report are Abbott Laboratories, Abiomed, Medtronic, Teleflex Incorporated, SynCardia Systems, Fresenius Medical Care AG & Co. KGaA, Getinge, CardiacAssist, Inc., Berlin Heart, Jarvik Heart, Inc., CARMAT, SENKO MEDICAL INSTRUMENT Mfg. CO., LTD., Angiodroid, and CardioDyme among others.
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart Pump Device Market is anticipated to reach up to USD 14.4 billion by 2032, here
News-ID: 3038005 • Views: …
More Releases from Global Insight Services

Stem Cell Umbilical Cord Blood Market to Reach $25.9 Bn by 2034, CAGR 14.2% | Ke …
Market Overview
Stem Cell Umbilical Cord Blood Market is gaining rapid traction as regenerative medicine and advanced therapies reshape the global healthcare landscape. Umbilical cord blood, once considered medical waste, is now recognized as a vital source of hematopoietic stem cells used to treat a wide range of diseases, including blood disorders, cancers, and genetic conditions. Parents across the world are increasingly opting for cord blood banking to secure future medical…

Seafood Packaging Market to Hit $34.2 Bn by 2034, CAGR 6.1% | Key Players: Seale …
Seafood Packaging Market Overview
Seafood Packaging Market is evolving rapidly as global seafood consumption continues to rise. With consumers demanding fresher, safer, and more sustainable options, packaging has become a critical element in the seafood value chain. The market encompasses advanced solutions such as vacuum packaging, modified atmosphere packaging, and retort packaging that extend shelf life and ensure product integrity. From protecting seafood during transportation to meeting sustainability standards, packaging plays…

Cannabis Cultivation Market Is Anticipated To Expand From $1,083 Million In 2024 …
Market Overview
The Cannabis Cultivation Market is emerging as one of the fastest-growing segments within the global agricultural and pharmaceutical industries. With the rising acceptance of cannabis for medical and recreational purposes, the market is undergoing a remarkable transformation. Cultivation practices are becoming increasingly sophisticated, supported by technological innovations and evolving regulatory frameworks. From indoor hydroponic systems to large-scale outdoor farms, cannabis cultivation is moving from small-scale production into a structured,…

Bispecific Antibodies Market Is Anticipated To Expand From $12.3 Billion In 2024 …
Market Overview
The Bispecific Antibodies Market represents one of the most promising frontiers in modern biotechnology, offering innovative therapeutic solutions for complex medical conditions. Unlike conventional monoclonal antibodies, bispecific antibodies are engineered to simultaneously target two distinct antigens, thereby improving treatment precision and efficacy. Their growing adoption is particularly evident in oncology and immunotherapy, where they are transforming the landscape of cancer treatment and autoimmune disease management. The rising demand for…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…